coronavirus

Healthcare

FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

March 31, 2020 admin Comments Off on FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

VANCOUVER, Washington, March 31, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the […]

Newsmakers

NexTech AR (OTC: NEXCF) Reports Boost in Demand for its Products as Coronavirus Drives Shopping From Home

March 18, 2020 admin Comments Off on NexTech AR (OTC: NEXCF) Reports Boost in Demand for its Products as Coronavirus Drives Shopping From Home

Coronavirus Driving Demand in E-commerce and Augmented Reality NEW YORK and TORONTO, March 18, 2020 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for e-commerce and AR learning applications, has been experiencing an […]